Cargando…

Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

OBJECTIVE: Fenfluramine has been shown to provide clinically meaningful and statistically significant reductions in convulsive seizure frequency in children and adolescents (aged 2‐18 years) with Dravet syndrome in two randomized, placebo‐controlled clinical trials. The objective of this analysis wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Joseph, Scheffer, Ingrid E., Lagae, Lieven, Nabbout, Rima, Pringsheim, Milka, Talwar, Dinesh, Polster, Tilman, Galer, Bradley, Lock, Michael, Agarwal, Anupam, Gammaitoni, Arnold, Morrison, Glenn, Farfel, Gail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756901/ https://www.ncbi.nlm.nih.gov/pubmed/33078386 http://dx.doi.org/10.1111/epi.16722

Ejemplares similares

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
por: Knupp, Kelly G., et al.
Publicado: (2022)

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
por: Lai, Wyman W., et al.
Publicado: (2020)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
por: Boyd, Brooks, et al.
Publicado: (2019)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
por: Schoonjans, A., et al.
Publicado: (2016)

Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017)

Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome
por: Li, Jing, et al.
Publicado: (2021)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
por: Sullivan, Joseph, et al.
Publicado: (2021)

Fenfluramine in the treatment of hypertensive patients with refractory obesity.
por: Scott, M. E., et al.
Publicado: (1975)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Risk of valvular heart disease associated with use of fenfluramine
por: Hopkins, Paul N, et al.
Publicado: (2003)

A review of fenfluramine for the treatment of Dravet syndrome patients
por: Simon, Kayla, et al.
Publicado: (2021)

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy
por: Samanta, Debopam
Publicado: (2022)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
por: Dahl, Charles F, et al.
Publicado: (2008)

Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis
por: Tabaee Damavandi, Payam, et al.
Publicado: (2023)

Thirty years of geometric morphometrics: Achievements, challenges, and the ongoing quest for biological meaningfulness
por: Mitteroecker, Philipp, et al.
Publicado: (2022)

13.4 Rapid-Onset Functional Tic-Like Behaviors During the COVID-19 Pandemic
por: Pringsheim, Tamara Milka
Publicado: (2022)

In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

The anorexic effect of DL-fenfluramine is dependent on animals' habituation to different food types
por: Yi, Sun Shin, et al.
Publicado: (2022)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells
por: Yao, Weijuan, et al.
Publicado: (2011)

Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome
por: Millett, David, et al.
Publicado: (2021)

Expedient syntheses of the N-heterocyclic carbene precursor imidazolium salts IPr·HCl, IMes·HCl and IXy·HCl
por: Hintermann, Lukas
Publicado: (2007)

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series
por: Aledo‐Serrano, Ángel, et al.
Publicado: (2022)

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Wijnen, Ben, et al.
Publicado: (2022)

Serotonin receptors in epilepsy: Novel treatment targets?
por: Sourbron, Jo, et al.
Publicado: (2022)

An influence of HCl and water co-adsorption at ice surfaces on HCl uptake
por: Kapko, V I, et al.
Publicado: (2002)

Heated lidocaine/tetracaine patch for treatment of patellar tendinopathy pain
por: Gammaitoni, Arnold R, et al.
Publicado: (2013)

Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib
por: Paillassa, Jérôme, et al.
Publicado: (2022)

Juxtaposition of the atrial appendages in a patient with a simple ventricular septal defect
por: Cleuziou, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1dnmhu6v44lfv3l4d2np96bqn